Clinical data indicate that allulose consumption enhances satiety signals and reduces subsequent food intake, potentially mediated through GLP-1 pathway activation
Commitment to Patient Success When you choose treatment through our clinic, you receive comprehensive assessment, dose titration, and ongoing monitoring designed to optimize outcomes and safety
Millions of people started taking GLP-1 Drugs (Semaglutide or Tirzepatide) after the trials ended and drugs reached the market
Studies and clinical trials show that when people stop taking GLP-1s, the appetite often comes back, and in many cases there is rapid weight regain, especially if nutrition and behavior changes werent made when on the medication, she says
Discontinue use and consult a doctor if unusual symptoms occur, or if you notice a rash or other allergic reactions
doi: 10.3390/ijms21113943 152